Showing results (1-10 of 95) with videos related to
Sort By:
Pageof 10
The Journal of Biological Chemistry|December 22, 2004
Purification, functional reconstitution, and characterization of the Saccharomyces cerevisiae isoprenylcysteine carboxylmethyltransferase Ste14pJessica L Anderson, Hilary Frase, Susan Michaelis, et al.Human Molecular Genetics|June 22, 2012
Human ZMPSTE24 disease mutations: residual proteolytic activity correlates with disease severityJemima Barrowman, Patricia A Wiley, Sarah E Hudon-Miller, et al.Biochemical and Biophysical Research Communications|July 22, 2008
HIV-protease inhibitors block the enzymatic activity of purified Ste24pSarah E Hudon, Catherine Coffinier, Susan Michaelis, et al.Disease Models & Mechanisms|May 26, 2018
ZMPSTE24 missense mutations that cause progeroid diseases decrease prelamin A cleavage activity and/or protein stabilityEric D Spear, Erh-Ting Hsu, Laiyin Nie, et al.Nature Chemical Biology|September 20, 2006
Therapeutic intervention based on protein prenylation and associated modificationsMichael H Gelb, Lucas Brunsveld, Christine A Hrycyna, et al.The Biochemical Journal|October 14, 2004
Prelamin A endoproteolytic processing in vitro by recombinant Zmpste24Douglas P Corrigan, Danuta Kuszczak, Antonio E Rusinol, et al.Biochemistry|April 6, 2005
N-Linked glycosylation of the human ABC transporter ABCG2 on asparagine 596 is not essential for expression, transport activity, or trafficking to the plasma membraneNdeye K Diop, Christine A HrycynaThe Enzymes|January 1, 2016
9 Structure and function of isoprenylcysteine carboxylmethyltransferase (Icmt): A key enzyme in CaaX processingJessica L Anderson, Christine A HrycynaBioorganic & Medicinal Chemistry Letters|May 29, 2012
Click chemistry-derived bivalent quinine inhibitors of P-glycoprotein-mediated cellular effluxJerrin Kuriakose, Christine A Hrycyna, Jean ChmielewskiCancer Drug Resistance (Alhambra, Calif.)|January 7, 2022
The roles of the human ATP-binding cassette transporters P-glycoprotein and ABCG2 in multidrug resistance in cancer and at endogenous sites: future opportunities for structure-based drug design of inhibitorsJason Goebel, Jean Chmielewski, Christine A HrycynaPageof 10